TP53 and neoplasm: We confirmed all exome-seq variants in the “common” gene set in all four tumor cell lines; the presence of Tp53 mutations in the FAT7 (R271H) and NBTII lines (R211W, I230T), and its absence in the C6 and DSL-6A/C1 cell lines, missense mutations for the oncogenes Ncor1 (E544D) across all four cells lines and Pick3ca in the C6 (C90Y) and the NBTII (M811 T) cell lines.